Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
cognitive decline, memory loss, and impaired daily functioning. While there is currently no …

There is an urgent need to develop safer and more effective modalities for the treatment of a
wide range of pathologies due to the increasing rates of drug resistance, undesired side …

Alzheimer's disease (AD) is a very common neurodegenerative disorder associated with
memory loss and a progressive decline in cognitive activity. The two major …

Cannabidiol (CBD), one of the most promising constituents isolated from Cannabis sativa,
exhibits diverse pharmacological actions. However, the applications of CBD are restricted …

Alzheimer's disease (AD), as a neurodegenerative disorder, usually develops slowly but
gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is …

Simple Summary The relatively high prevalence of microbial infections and the rising
resistance to traditional antibiotics are the causes of the need for revolutionary antibiotics …

One of the pathological hallmarks of Alzheimer's disease (AD) is the formation of amyloid-β
plaques. Since acetylcholinesterase (AChE) promotes the formation of such plaques, the …

The main feature of neurodegenerative diseases, including Alzheimer's disease, is the
network of complex and not fully recognized neuronal pathways and targets involved in their …

Esterases are hydrolases that catalyze the hydrolysis of esters into the corresponding acids
and alcohols. The development of fluorescent probes for detecting esterases is of great …

The complexity of Alzheimer's disease (AD) and several side effects of currently available
medication inclined us to search for a novel natural cure by targeting multiple key regulatory …